Table 2.

Summary of immune-related adverse events

	Grade 1–2	Grade 3–4
Any immune-related adverse events	6 (35%)	0
Dermatological (rash, pruritus, erythema multiforme, psoriasis)	4 (24%)	0
Gastrointestinal (diarrhoea, nausea, vomiting)	2 (12%)	0
Pancreatic (amylases or lipase increase)	1 (6%)	0
Pneumonitis	2 (12%)	0
Articular and muscle pain	1 (6%)	0
Decrease appetite	1 (6%)	0

Data are number of patients (%). Population included 17 patients.